WallStreetZenWallStreetZen

NASDAQ: MAZE
Maze Therapeutics Inc Stock Ownership - Who owns Maze Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Maze Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Harold BernsteinPresident RD CMO2026-02-02100$47.23
$4.72kSell
Amy BachrodtSVP Finance2026-02-024,844$10.42
$50.47kBuy
Amy BachrodtSVP Finance2026-02-02156$10.42
$1.63kBuy
Amy BachrodtSVP Finance2026-02-02200$44.15
$8.83kSell
Amy BachrodtSVP Finance2026-02-024,064$46.03
$187.07kSell
Amy BachrodtSVP Finance2026-02-02736$46.63
$34.32kSell
Harold BernsteinPresident RD CMO2026-02-0215,000$10.42
$156.30kBuy
Harold BernsteinPresident RD CMO2026-02-02600$44.21
$26.52kSell
Harold BernsteinPresident RD CMO2026-02-028,364$45.89
$383.82kSell
Harold BernsteinPresident RD CMO2026-02-025,936$46.37
$275.27kSell

1 of 5

MAZE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MAZE insiders and whales buy or sell their stock.

MAZE Shareholders

What type of owners hold Maze Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Trv GP IV LLC12.62%6,073,958$286.81MInstitution
Third Rock Ventures IV LP11.27%5,424,758$256.16MInsider
Frazier Life Sciences Management LP9.49%4,567,274$215.67MInstitution
Arch Venture Management LLC8.56%4,120,053$194.55MInstitution
Deep Track Capital LP8.21%3,948,910$186.47MInstitution
Alphabet Inc5.01%2,412,471$113.92MInstitution
A16z Capital Management LLC3.54%1,702,225$80.38MInstitution
Matrix Capital Management Company LP3.44%1,653,684$78.09MInstitution
Vanguard Group Inc2.77%1,334,955$63.04MInstitution
Blackrock Inc2.73%1,316,016$62.14MInstitution

1 of 3

MAZE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MAZE87.15%12.85%Net SellingNet Buying
RARE85.64%14.36%Net SellingNet Selling
DYN83.29%16.71%Net BuyingNet Selling
MLYS67.82%32.18%Net BuyingNet Selling
GLPG47.65%0.00%
View Top Biotech Stocks

Maze Therapeutics Stock Ownership FAQ

Who owns Maze Therapeutics?

Maze Therapeutics (NASDAQ: MAZE) is owned by 89.30% institutional shareholders, 13.16% Maze Therapeutics insiders, and 0.00% retail investors. Third Rock Ventures IV LP is the largest individual Maze Therapeutics shareholder, owning 5.42M shares representing 11.27% of the company. Third Rock Ventures IV LP's Maze Therapeutics shares are currently valued at $255.18M.

If you're new to stock investing, here's how to buy Maze Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.